Buy AbbVie Stock | ABBV Stock Price & Latest News | Public

AbbVie

$0.00 (0.00%)Today

About ABBV

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, includin...Read more

Community

People who own or watch this stock

News

News image
FDA Approves Expanded BOTOX® (onabotulinumtoxinA) Label for the Treatment of Pediatric Patients with Spasticity
0
0

Buy any stock with any amount of money.

Download the App
Download the app

What Wall Street Thinks

Rating

What Wall St. analysts suggest for this stock

1.6

Price Targets

What analysts think this stock will be worth

$97.88
current
$107.64
average

Events

List of events that could affect this stock.

01May

Earnings data Q1 2020

31Jul

Earnings data Q2 2020

Earnings

The value each share was expected to gain vs. the value that each share actually gained

2.67
1.78
0.89
0
Q4 2019
Q1 2020
Q2 2020
Q3 2020

Expected EPS
Q3 2020

$2.67

Actual EPS
Q3 2020

Stats

Market Cap$170,64B
Volume331,47k
Price-to-Earnings Ratio17.14
Dividend Rate$4.50
Dividend Yield4.60%
1 Year High$100.69
1 Year Low$62.55
Open$97.50
High$99.56
Low$97.00

Buy any stock with any amount of money.

Download the App
Download the app